TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 408,255 | 435,719 | 315,943 |
Financial expenses | 4,629 | 187 | 1,778 |
Earnings before taxes | 4,364 | 10,951 | 5,211 |
EBITDA | 7,223 | 11,046 | 5,097 |
Total assets | 192,698 | 152,382 | 209,584 |
Current assets | 192,442 | 152,147 | 208,983 |
Current liabilities | 132,504 | 99,073 | 163,367 |
Equity capital | 46,012 | 40,066 | 32,564 |
- share capital | 101 | 95 | 98 |
Employees (average) | 21 | 19 | 18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 23.9% | 26.3% | 15.5% |
Turnover per employee | 19,441 | 22,933 | 17,552 |
Profit as a percentage of turnover | 1.1% | 2.5% | 1.6% |
Return on assets (ROA) | 4.7% | 7.3% | 3.3% |
Current ratio | 145.2% | 153.6% | 127.9% |
Return on equity (ROE) | 9.5% | 27.3% | 16.0% |
Change turnover | -58,381 | 129,271 | 4,567 |
Change turnover % | -13% | 42% | 1% |
Chg. No. of employees | 2 | 1 | 2 |
Chg. No. of employees % | 11% | 6% | 13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.